SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001725160-21-000018
Filing Date
2021-02-03
Accepted
2021-02-03 17:27:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G zentalis-anthonysunschedul.htm SC 13G 39227
  Complete submission text file 0001725160-21-000018.txt   40693
Mailing Address C/O AISLING CAPITAL 888 SEVENTH AVENUE, 30TH FLOOR NEW YORK NY 10106
Business Address
SUN ANTHONY Y (Filed by) CIK: 0001377952 (see all company filings)

Type: SC 13G

Mailing Address 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018
Business Address 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Subject) CIK: 0001725160 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91478 | Film No.: 21587447
SIC: 2834 Pharmaceutical Preparations